2023年08月22日发布 | 194阅读
神经介入-动脉瘤

MCA dissecting AN treated via “T” stent technique with (PLCS)

张晓龙教授团队

复旦大学附属华山医院

达人收藏

Review

History

60 y/o male.
• Suffered from transient dizziness twice 15 days ago. Local hospital CTA detected a left middle cerebral inferior trunk dissecting aneurysm.

• Medication: Aspirin, Clopidogrel, Metoprolol, Rosuvastatin, Estazolam (艾司唑仑).

• Past medical history: No HTN, no DM, no smoking cigarettes and/or alcohol consumption. 2022.06 coronary artery stenting.

• NE:(-).

60岁,男性。

• 15天内发作性头晕2次,当地医院CTA提示左侧大脑中动脉下干夹层动脉瘤。

• 药物:阿司匹林,氯吡格雷,美托洛尔,瑞舒伐他汀,艾司唑仑。

• 既往史:否认高血压、糖尿病,否认吸烟、饮酒史。2022.06心脏支架植入术。

• 神经查体:-。

Figure 1. CTA revealed a left middle cerebral bifurcation dissecting aneurysm.

图 1. CTA提示左侧大脑中动脉分叉部夹层动脉瘤。

Figure 2 GIF. DSA confirmed a left middle cerebral inferior trunk initial segment dissecting aneurysm with irregular shape and daughter sac.

图 2 GIF. DSA证实左侧大脑中动脉下干起始部夹层动脉瘤,形态不规则,伴子瘤形成。

Figure 3. A large left MCA inferior trunk initial segment dissecting aneurysm with daughter sac was observed. The inferior trunk initial segment presented with an acute curve.

图 3. 3D重建提示左侧大脑中动脉下干起始部夹层动脉瘤伴子瘤,大脑中动脉下干起始部有急弯。

1

Strategy

1.A large left MCA inferior trunk initial segment dissecting aneurysm with daughter sacs indicated a high rupture risk which should be treated.

2.Post large coils stenting technique will be adopted to protect the inferior trunk.

3.Due to an acute curve of inferior trunk initial segment, Atlas stent was preferred. Solitaire stent harboured a relative high ischemic or occlusion risk.

4.Solitaire stent will be deployed into the superior trunk to straightened the angle in order to decrease recurrence rate.
5.If this aneurysm recurred in follow up period, pipeline can be deployed in the superior trunk.
6.General heparinization was performed after inferior trunk super-selection (dangerous procedure).

1.左侧大脑中动脉下干起始部大夹层动脉瘤伴子瘤,破裂风险高,建议治疗。

2.计划采用大圈支架后释放技术保护大脑中动脉下干。

3.由于下干起始部急弯,选用Atlas支架。Solitaire支架相对缺血或血管闭塞事件风险较高。

4.选用Solitaire支架置于上干,拉直成角,改变血流冲击方向,降低复发风险。

5.若随访时动脉瘤复发,可上干置入pipeline支架。

6.全身肝素化时机:由于下干超选风险高,下干超选成功后再行肝素化。

2

Operation

Figure 4 GIF. Working projection selection: An size 5.8*4.69mm, neck 1.92mm, proximal parent artery diameter 2.22mm, distal parent artery diameter 1.73mm. 6F Envoy DA guiding catheter was placed into left cavernous segment and Nimodipine 1ml was administered. Synchro-II microwire and spiral-curved SL-10 microcatheter were navigated into inferior trunk via skating technique (Noting: Kept the microcatheter tension and persistently advanced the microwire). Re-roadmap confirmed no hemorrhage. General heparization and Nimodipine 1ml were administered.

图 4 GIF. 工作角度:动脉瘤大小5.8*4.69mm,瘤颈1.92mm,近端载瘤动脉直径2.22mm,远端载瘤动脉直径1.73mm。将Envoy DA导引导管置于左侧颈内动脉海绵窦段,给予尼莫地平1ml。通过溜冰技术将Synchro-II微导丝和SL-10微导管(头端塑螺旋形)超选入大脑中动脉下干(注意:超选时保持微导管张力,微导丝向前超选)。随后重新路图造影证实无出血。行全身肝素化,给予尼莫地平1ml。

Figure 5. C-tipped Prowler plus microcatheter was navigated into superior trunk and a Solitaire stent 4*20mm was deployed. The superior trunk was straightened.

图 5. 将头端塑“C”弯的Prowler plus微导管置于大脑中动脉上干, Solitaire 4*20mm支架释放保护上干及瘤颈。支架释放后上干拉直。

Figure 6 GIF. Another SL-I0 microcatheter with “C” tip was advanced into the sac. Inserted a Tonbridge Feng 2d 5mm*15cm coil, then deployed an Atlas 3*15mm stent at the inferior trunk. Continued inserting 3 coils (Target helical 4mm*15cm (*2) & Target 360 2mm*3cm). Tirofiban 15ml was administered.
图 6 GIF. 选用另一枚SL-I0微导管头端塑“C”形后置于瘤腔。填入Tonbridge Feng 2d 5mm*15cm弹簧圈,下干释放Atlas 3*15mm支架覆盖瘤颈。瘤腔内继续填入3枚弹簧圈(Target helical 4mm*15cm (*2) & Target 360 2mm*3cm)。经导引导管给予替罗非班15ml。

Figure 7 GIF. Angiograms showed the aneurysm was packed satisfactorily. Tirofiban 7ml was administered and waited.

图 7 GIF. 复查造影动脉瘤栓塞满意。经导管给予替罗非班7m。然后等待。

Figure 8 GIF. Parent artery was patent after waiting for 20 minutes.

图 8 GIF. 等待20min后复查造影,载瘤动脉通畅。

Figure 9 GIF. Post-operative dyna-CT did not demonstrate any hemorrhage.

图 9 GIF. 术后dyna-CT未见出血。

3

Post-Operation

NE: Bilateral normal muscle strength, eye movement normal, bilateral Babinski negative, no new neurological defect.

Medication:

Tirofiban 7ml/h maintained for 17 hours.
Aspirin for long term and Clopidogrel for 3 months.

查体:双侧肌力正常,眼球各项运动佳,双侧巴氏征阴性,无新发神经功能缺损。

药物:
替罗非班7ml/h维持17h。
阿司匹林长期口服,氯吡格雷口服3月。


Video 1. The aneurysm was no relapsed and parent artery patent by 7 month follow up.
视频 1. 7个月随访动脉瘤无复发或残留,载瘤动脉通畅。

Figure 10. Solitaire straightened the superior trunk.

图 10. Solitaire拉直大脑中动脉上干。


Video 2. Intracranial vessels were intact by 7 month follow up.

视频 2. 7个月随访颅内血管完好。

4

Summary

1.A large left MCA inferior trunk initial segment dissecting aneurysm with daughter sacs indicating a high rupture risk should be treated.

2.Post large coils stenting technique was adopted to preserve the inferior trunk.
3.Solitaire stent was deployed into the superior trunk to straighten the angle in order to decrease recurrence rate.

4.Due to an acute curve of inferior trunk initial segment, Atlas stent was preferred instead of Solitaire stent with a relative high ischemic or occlusion risk.

5.Since Atlas stent was soft, this stent should be deployed early after the first soft frame coil embolized.

6.General heparinization was performed after inferior trunk super-selection (dangerous procedure).

7.If this aneurysm recurred in follow up period, pipeline can be deployed in the superior trunk. Pipeline was difficult to open in the inferior trunk.

8.Pipeline was not recommended in superior trunk at the first stage considering delayed stenosis or occlusion and delayed rupture due to daughter sac.


1.左侧大脑中动脉下干起始部大夹层动脉瘤伴子瘤,破裂风险高,建议治疗。

2.我们采用大圈支架后释放技术保护下干。
3.Solitaire支架置于上干,拉直成角,改变血流冲击方向,降低复发风险。

4.由于下干起始部急弯,选用Atlas支架,因为Solitaire支架相对缺血或血管闭塞事件风险较高。

5.Atlas支架比较软,所以支架在第一枚弹簧圈稳定成篮后再释放。

6.全身肝素化时机:由于下干超选风险高,下干超选成功后再行肝素化。

7.若随访时动脉瘤复发,考虑下干pipeline可能会打开困难,可在上干置入pipeline支架。

8.考虑到血流导向装置延迟狭窄或闭塞及延迟破裂风险,上干置入Pipeline支架不是一期治疗的首选方案。


https___www.medtion.com_app_subspecialty_index.html_channelId=4&channelTitle=介入&mpId=730&ocsId=788.png

点击扫描上方二维码

查看更多“介入”内容


声明:脑医汇旗下神外资讯、神介资讯、脑医咨询、Ai Brain 所发表内容之知识产权为脑医汇及主办方、原作者等相关权利人所有。

投稿邮箱:NAOYIHUI@163.com 

未经许可,禁止进行转载、摘编、复制、裁切、录制等。经许可授权使用,亦须注明来源。欢迎转发、分享。

投稿/会议发布,请联系400-888-2526转3。

最新评论
发表你的评论
发表你的评论